Finance

Lists
SIBN:NASDAQ
SI-Bone Inc
23,03 $
-1,62%
(-0,38) 1D
17 қар., 11:35:03 GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SIBN...
Open
23,21 $
High
23,46 $
Low
22,94 $
Mkt. cap
1,04 млрд
Avg. vol.
823,72 м.
Volume
123,16 м.
52-wk high
25,92 $
52-wk low
11,48 $
EPS
-0,31 $
Beta
0,64
Shares outstanding
45,11 млн
No. of employees
376
Open
23,21 $
High
23,46 $
Low
22,94 $
Mkt. cap
1,04 млрд
Avg. vol.
823,72 м.
Volume
123,16 м.
52-wk high
25,92 $
52-wk low
11,48 $
EPS
-0,31 $
Beta
0,64
Shares outstanding
45,11 млн
No. of employees
376
News stories
From web sources and news partners
About SI-Bone Inc
CEO-
Employees376
Founded2008
HeadquartersСанта Клара, Калифорния, Америка Құрама Штаттары
SectorHealth Care
IndustryMedical device
Analyst ratings
Based on 6 analysts giving stock ratings to SIBN in the past 3 months
Strong buy
Buy
6
Hold
0
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for SIBN in the last 3 months.
Highest
Current 23,03 $
29,00 $ (+25,92%)
Average
25,83 $ (+12,16%)
Lowest
23,00 $ (-0,13%)
Analyst
Recommendation
Action
Price target
Projected
Date
Travis Steed
Bank of America Securities
Buy
Maintained
29,00 $
+25,9%
11/09/2026
Mathew Blackman
TD Cowen
Buy
Maintained
23,00 $
-0,1%
11/03/2026
Matthew O'Brien
Piper Sandler
Buy
Maintained
25,00 $
+8,6%
11/03/2026
Caitlin Roberts
Canaccord Genuity
Buy
Reiterated
27,00 $
+17,2%
11/03/2026
Patrick Wood
UBS
Buy
Reiterated
26,00 $
+12,9%
11/03/2026
Richard Newitter
Truist Financial
Buy
Maintained
25,00 $
+8,6%
10/14/2026
David Saxon
Needham
Buy
Reiterated
27,00 $
+17,2%
08/04/2026
Unknown Analyst
UBS
Buy
Initiated
24,00 $
+4,2%
07/28/2026
Andrew Ranieri
Morgan Stanley
Buy
Reiterated
18,00 $
-21,8%
05/11/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
2026 ж. қыр.
Revenue
56,35 млн
52,59 млн
56,01 млн
55,70 млн
Cost of goods sold
11,82 млн
10,64 млн
11,46 млн
11,54 млн
Cost of revenue
11,82 млн
10,64 млн
11,46 млн
11,54 млн
Research and development expenses
4,36 млн
4,19 млн
5,22 млн
4,56 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
42,63 млн
42,84 млн
44,13 млн
43,96 млн
Operating expense
46,99 млн
47,04 млн
49,35 млн
48,52 млн
Total operating expenses
58,81 млн
57,68 млн
60,82 млн
60,06 млн
Operating income
-2,46 млн
-5,09 млн
-4,81 млн
-4,35 млн
Other non operating income
-
-
-
-
EBT including unusual items
-1,64 млн
-4,33 млн
-4,09 млн
-3,62 млн
EBT excluding unusual items
-1,64 млн
-4,33 млн
-4,09 млн
-3,62 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1,64 млн
-4,33 млн
-4,09 млн
-3,62 млн
Net profit margin
-2,92%
-8,24%
-7,30%
-6,50%
Earnings per share
-0,04
-0,10
-0,09
-0,08
Interest and investment income
1,45 млн
1,35 млн
1,33 млн
1,35 млн
Interest expense
-630,00 м.
-592,00 м.
-598,00 м.
-608,00 м.
Net interest expenses
817,00 м.
758,00 м.
734,00 м.
740,00 м.
Depreciation and amortization charges
-
-
-
-
EBITDA
-825,00 м.
-3,48 млн
-3,13 млн
-2,66 млн
Gain or loss from assets sale
185,00 м.
332,00 м.
254,00 м.
23,00 мың
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google қолданбалары